About
Surenano Science Ltd — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 24 2026
SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio
Feb 23 2026
SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development
Dec 12 2025
SureNano Announces Stock Option Grant
Dec 10 2025
SureNano Announces Closing of $1,250,000 Private Placement
Nov 19 2025
SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development
Recent Videos

SureNano Science Ltd. (SURE:CSE)
Apr 21, 2022

SureNano Science Ltd. (SURE:CSE)
Feb 18, 2022
Google Übersetzer